Multi-Center, Randomized, Double-Blind, Repeated Doses Study to Evaluate the Safety, Tolerability and Pharmacodynamic Activity of Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2012
At a glance
- Drugs TPI 1020 (Primary) ; Budesonide
- Indications Asthma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 04 Nov 2008 Results presented at ERS
- 07 Nov 2007 Company added in the association field and additional lead trial centre identified as reported by ClinicalTrials.gov.
- 29 May 2006 New trial record.